Clinical Trials on Cost Sharing, Acute Coronary Syndrome in New Zealand

Total 677 results

AstraZeneca
Duke Clinical Research Institute

Completed

Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study (ARTEMIS)

Cost Sharing, Acute Coronary Syndrome

United States, Puerto Rico
National University Heart Centre, Singapore
AstraZeneca

Recruiting

PASSIvation of Vulnerable Plaque With AZD5718 in AcuTe Coronary syndromE (PASSIVATE)

Acute Coronary Syndrome

Australia, New Zealand, Singapore
Zealand University Hospital
University of Copenhagen; Pharma Nord; Psychiatric Research Unit, Region Zealand...

Completed

The Effect of MElatonin on Depression, Anxiety, CIrcadian and Sleep Disturbances in Patients After Acute Myocardial Syndrome (MEDACIS)

Depression | Acute Coronary Syndrome

Denmark
NYU Langone Health
Doris Duke Charitable Foundation

Active, not recruiting

Study of Women With Acute Coronary Syndromes and Nonobstructive Coronary Artery Disease (SWAN)

Acute Coronary Syndromes

United States
Novartis
The TIMI Study Group

Completed

Efficacy and Safety of Aliskiren and Valsartan Versus Placebo in Patients Stabilized Following an Acute Coronary Syndrome

Myocardial Ischemia | Post Acute Coronary Syndrome

Germany, Spain, United States, Belgium, Canada, Czech Republic, Hungary, Netherlands, Poland, Russian Federation, Sweden
Medstar Health Research Institute
GlaxoSmithKline

Completed

Switching From Fondaparinux to Bivalirudin or Unfractionated Heparin in ACS Patients Undergoing PCI (SWITCHIII)

Acute Coronary Syndromes

United States, Canada
AstraZeneca

Completed

LUNAR IIIb Study Comparing Rosuvastatin and Atorvastatin in Subjects With Acute Coronary Syndromes

Acute Coronary Syndromes

United States, Costa Rica, Panama, El Salvador, Morocco
Cerenis Therapeutics, SA
South Australian Health and Medical Research Institute

Completed

CER-001 Atherosclerosis Regression ACS Trial (CARAT)

Acute Coronary Syndromes

United States, Australia, Netherlands, Hungary
New York State Psychiatric Institute
National Alliance for Research on Schizophrenia and Depression

Terminated

A Trial of Inflammatory Markers, Depressive Symptoms, and Heart Disease (CHIME)

Depression | Coronary Artery Disease (CAD) | Acute Coronary Syndrome (ACS)

United States
Biosite

Completed

Myeloperoxidase and Multi-Markers In the Diagnosis of Diagnoses of Acute Coronary Syndrome (MIDAS) - Sample Procurement

Acute Coronary Syndrome (ACS)

United States
AstraZeneca

Completed

Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical Registry

Acute Coronary Syndromes

United States
Bristol-Myers Squibb
Pfizer; Duke Clinical Research Institute

Completed

A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart

Acute Coronary Syndromes

Australia, Germany, Poland, United States, Spain, Brazil, France, Netherlands, Argentina, Mexico, Russian Federation, Colombia, Austria, Belgium, Czechia, Hungary, Israel, Peru, Switzerland, Korea, Republic of, Canada, Romania, Sweden, Ukrai... and more
Sanofi
Bristol-Myers Squibb

Completed

Clopidogrel as Adjunctive Reperfusion Therapy - Thrombolysis in Myocardial Infarction (CLARITY-TIMI28)

Acute Coronary Syndromes

Russian Federation, Belgium, Brazil, France, Germany, Hungary, Italy, Mexico, Netherlands, South Africa, Spain, Sweden, United States, Argentina, Australia, Ireland, Israel, Turkey, Austria, Poland, Canada, Portugal, Puerto Rico, United...
SB Technology, Inc.

Recruiting

MCG Discovery Study in Emergency Departments

NSTEMI - Non-ST Segment Elevation MI | ACS - Acute Coronary Syndrome

United States
Stony Brook University
Hennepin County Medical Center, Minneapolis

Unknown

EKG Criteria and Identification of Acute Coronary Occlusion

Acute Coronary Syndrome | STEMI | NSTEMI - Non-ST Segment Elevation MI | Non ST Segment Elevation Myocardial Infarction | Non-ST Elevation Myocardial Infarction | STEMI - ST Elevation Myocardial Infarction | Acute Coronary Artery Thrombosis (Diagnosis) | Non ST Segment Elevation Acute Coronary Syndrome and other conditions

United States
Ortho-Clinical Diagnostics, Inc.

Unknown

VITROS Immunodiagnostic Products hs Troponin I

Myocardial Infarction | Acute Coronary Syndrome (ACS)

United States
OrbusNeich
Duke Clinical Research Institute; OrbusNeich Medical K.K.

Completed

HARMONEE - Japan-USA Harmonized Assessment by Randomized, Multi-Center Study of OrbusNEich's Combo StEnt (HARMONEE)

Coronary Arteriosclerosis | Non ST Segment Elevation Acute Coronary Syndrome

United States, Japan
Regado Biosciences, Inc.

Completed

A Study Assessing the REG1 Anticoagulation System Compared Heparin in Subjects With Acute Coronary Syndrome (RADAR)

Acute Coronary Syndrome (ACS)

United States, Canada, Germany, France
VA Office of Research and Development
NYU Langone Health

Completed

Colchicine in Percutaneous Coronary Intervention (Colchicine-PCI)

Coronary Artery Disease | Acute Coronary Syndrome

United States
National Cancer Institute (NCI)

Active, not recruiting

Using the Anticancer Drug Olaparib to Treat Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome With an Isocitrate Dehydrogenase (IDH) Mutation

Acute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome | Acute Myeloid Leukemia Post Cytotoxic Therapy

United States
Jonathann Kuo, MD

Active, not recruiting

Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Long COVID (DSBLongCOVID)

SARS-CoV2 Infection | Post-COVID-19 Syndrome | Dysautonomia | Post Acute COVID-19 Syndrome | Long COVID | Long Covid19 | COVID-19 Recurrent | Post-Acute COVID-19 | Post-Acute COVID-19 Infection | Post Acute Sequelae of COVID-19 | Dysautonomia Like Disorder | Dysautonomia Orthostatic Hypotension Syndrome | Post... and other conditions

United States
National Cancer Institute (NCI)

Completed

Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases

Primary Myelofibrosis | Chronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Recurrent Disease | Recurrent Adult Acute Lymphoblastic Leukemia | Secondary Myelodysplastic Syndrome | de Novo Myelodysplastic... and other conditions

United States, Canada, New Zealand
University Hospital, Essen

Completed

Epicardial Adipose Tissue Thickness PredIcts Obstructive Coronary Artery Disease in Acute Coronary Syndrome Patients (EPIC-ACS)

Acute Coronary Syndrome

Germany
Bristol-Myers Squibb

Completed

Safety Study of Apixaban in Recent Acute Coronary Syndrome

Acute Coronary Syndrome (ACS)

Canada, Italy, Poland, Sweden, United States, Spain, Austria, Denmark, France, Belgium, Israel, Germany, Russian Federation, United Kingdom
Medicure
SCRI Development Innovations, LLC

Completed

Shortened Aggrastat® Versus Integrilin in Percutaneous Coronary Intervention (SAVI-PCI)

Myocardial Infarction | Unstable Angina | Acute Coronary Syndromes

United States
Otsuka Australia Pharmaceutical Pty Ltd

Recruiting

A Study Comparing Treatment Preference Between Oral Decitabine/Cedazuridine and Azacitidine in Myelodysplastic Syndrome, Low-Blast Acute Myeloid Leukemia, or Chronic Myelomonocytic Leukemia (PREFER-HMA)

Myelodysplastic Syndromes | Leukemia, Myeloid, Acute | Leukemia, Myelomonocytic, Chronic | Patient Preference

New Zealand, Australia
Columbia University
Roche Pharma AG

Completed

5th Generation cTnT in ED ACS

Acute Coronary Syndrome

United States
Angel Medical Systems
Symbios Clinical

Completed

AngelMed for Early Recognition and Treatment of STEMI (ALERTS)

Acute Coronary Syndrome | Coronary Occlusion | Acute Myocardial Infarction (AMI)

United States
Winthrop University Hospital

Terminated

Effects of Standard Treatment of Acute Coronary Syndromes on Macrophage Activity as Measured by Serum Neopterin

Acute Coronary Syndrome

United States
National Cancer Institute (NCI)

Recruiting

BLAST MRD AML-1: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 1- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With Intensive Chemotherapy as Frontline Therapy in Patients With Acute Myeloid Leukemia

Acute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Secondary Acute Myeloid Leukemia | Acute Myeloid Leukemia Post Cytotoxic Therapy

United States
Eli Lilly and Company

Completed

Clopidogrel to Prasugrel in Acute Coronary Syndrome (ACS) Patients

Acute Coronary Syndrome

India
Far Eastern Memorial Hospital
National Taiwan University Hospital

Active, not recruiting

Magnetic Nanoparticles System in Acute Coronary Syndrome

Acute Coronary Syndrome

Taiwan
Northwell Health
Toshiba America Medical Systems, Inc.

Enrolling by invitation

The Value of CT-FFR Compared to CCTA or CCTA and Stress MPI in Low to Intermediate Risk ED Patients With Toshiba CT-FFR

Coronary Artery Disease | Chest Pain | Acute Coronary Syndrome | Acute Myocardial Infarction

United States
St. Luke's-Roosevelt Hospital Center

Completed

ProspEctive First Evaluation in Chest Pain Trial (PERFECT)

Chest Pain | Shortness of Breath | Suspected Acute Coronary Syndrome

United States
Juan J Badimon
AstraZeneca

Completed

Antithrombotic Effects of Ticagrelor Versus Clopidogrel

Acute Coronary Syndrome

United States
Tallikut Pharmaceuticals, Inc.
Massachusetts General Hospital; Icahn School of Medicine at Mount Sinai; University... and other collaborators

Completed

Phase 2 Study in Vascular Inflammation on Patients After an Acute Coronary Syndrome Event

Acute Coronary Syndrome

United States
GlaxoSmithKline

Completed

Phase I Study of GW856553 (Losmapimod)

Acute Coronary Syndrome

Australia
Integrated Medical Research LLC
New York State Department of Health; Alere San Diego

Completed

Improving the Management of Acute Coronary Syndromes in the Emergency Department (RACE)

Acute Coronary Syndrome

United States
Columbia University
National Institutes of Health (NIH); National Center for Advancing Translational...

Suspended

Telehealth-enhanced Hybrid Cardiac Rehabilitation Among Acute Coronary Syndrome Survivors

Myocardial Infarction | Acute Coronary Syndrome

United States
National Cancer Institute (NCI)
Childrens Oncology Group (COG); LLS PedAL LLC

Recruiting

Highest Dose of Uproleselan in Combination With Fludarabine and Cytarabine for Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Mixed Phenotype Acute Leukemia Relapsed or Refractory and That Expresses E-selectin Ligand on the Cell Membrane

Down Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome | Recurrent Mixed Phenotype Acute Leukemia | Refractory Mixed Phenotype Acute Leukemia | Acute Myeloid Leukemia Post Cytotoxic Therapy | Myelodysplastic...

United States
Columbia University
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

Improving Medication Adherence in Post-ACS Patients

Medication Adherence | Acute Coronary Syndrome

United States
National Cancer Institute (NCI)

Active, not recruiting

BLAST MRD AML-2: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 2- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With Azacitidine and Venetoclax as Frontline Therapy in Unfit Patients With Acute Myeloid Leukemia

Acute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Secondary Acute Myeloid Leukemia | Acute Myeloid Leukemia Post Cytotoxic Therapy

United States
Biosite

Completed

Multi-Markers In the Diagnosis of Acute Coronary Syndrome (Midas 3)

Acute Coronary Syndrome

United States
Columbia University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Investigating Fear Of Recurrence as a Modifiable Mechanism of Behavior Change (INFORM)

Medication Adherence | Acute Coronary Syndrome | Fear

United States
NeuroActiva, Inc.
Biomed Industries, Inc.

Unknown

A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19 (OPV-NA831)

Covid19 | SARS-CoV-2 | SARS-CoV Infection | SARS (Severe Acute Respiratory Syndrome)

New Zealand, United States
National Cancer Institute (NCI)

Active, not recruiting

Pevonedistat and Belinostat in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome

United States
Yale University
National Heart, Lung, and Blood Institute (NHLBI); Ohio State University

Completed

Acute Coronary Syndrome and Care-Seeking Delay: A Web Based Behavioral Study

Acute Coronary Syndrome | Acute Myocardial Infarction | Unstable Angina | Heart Attack

United States
AstraZeneca

Completed

Multicentre Retrospective Study to Understand Anti-thrombotic Treatment Patterns and Outcomes of Acute Coronary Syndrome (ACS) Patients (TRACE)

Acute Coronary Syndrome

India
Montefiore Medical Center
Albert Einstein College of Medicine

Terminated

Study Comparing CT Scan and Stress Test in Patients With Known Coronary Artery Disease Hospitalized for Chest Pain (PROSPECT-CAD)

Coronary Artery Disease | Angina Pectoris | Acute Coronary Syndrome | Unstable Angina

United States
Memorial Sloan Kettering Cancer Center

Completed

Maintenance Low Dose 5'-Azacitidine Post T Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Myelodysplastic Syndrome and Acute Myelogenous Leukemia With High Risk for Post-Transplant Relapse

Myelodysplastic Syndromes (MDS) | Acute Myelogenous Leukemia (AML)

United States

Clinical Trials on Cost Sharing, Acute Coronary Syndrome in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uganda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations